What Do We Know about Thromboprophylaxis and Its Monitoring in Critically Ill Patients?

por Cauchie, Philippe, Piagnerelli, Michael
Publicado 2021

Thromboprophylaxis in Critically Ill Coronavirus Disease 2019 Patients

por Piagnerelli, Michaël, Cauchie, Philippe, Vancutsem, Maxime, Thooft, Aurélie, Zouaoui Boudjeltia, Karim, Biston, Patrick, Wautrecht, Jean-Claude
Publicado 2020

Plasma fibrinolysis is related to the degree of organ dysfunction but not to the concentration of von Willebrand Factor in critically ill patients

por Boudjeltia, Karim Zouaoui, Ollieuz, Sandra, Piagnerelli, Michael, Biston, Patrick, Cauchie, Philippe, Vincent, Jean-Louis, Brohee, Dany, Vanhaeverbeek, Michel
Publicado 2009

Relationship between CRP and hypofibrinolysis: Is this a possible mechanism to explain the association between CRP and outcome in critically ill patients?

por Zouaoui Boudjeltia, Karim, Piagnerelli, Michael, Brohée, Dany, Guillaume, Michel, Cauchie, Philippe, Vincent, Jean-Louis, Remacle, Claude, Bouckaert, Yves, Vanhaeverbeek, Michel
Publicado 2004

Ir-CPI, a coagulation contact phase inhibitor from the tick Ixodes ricinus, inhibits thrombus formation without impairing hemostasis

por Decrem, Yves, Rath, Géraldine, Blasioli, Virginie, Cauchie, Philippe, Robert, Séverine, Beaufays, Jérôme, Frère, Jean-Marie, Feron, Olivier, Dogné, Jean-Michel, Dessy, Chantal, Vanhamme, Luc, Godfroid, Edmond
Publicado 2009